This 2015 retrospective study evaluated the maintenance of hair density in 50 male patients with androgenetic alopecia (AGA) who transitioned from oral finasteride to a topical formulation containing 5% minoxidil and 0.1% finasteride. After two years of oral finasteride and minoxidil therapy, patients switched to the topical regimen. Results showed
